Prime Medicine Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
15 Feb 24 | BuyUS$20,000,000 | Arch Venture Partners, L.P. | Company | 3,200,000 | US$6.25 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
General Public | 68,963 | 0.054% |
Public Companies | 11,006,163 | 8.63% |
Individual Insiders | 25,499,104 | 20% |
VC/PE Firms | 30,519,092 | 23.9% |
Institutions | 60,502,258 | 47.4% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 38.3%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
20,156,945 | US$67.3m | 0% | no data | |||
15,456,594 | US$51.6m | 0% | 4.97% | |||
15,062,498 | US$50.3m | 0% | 2.86% | |||
11,006,163 | US$36.8m | 0% | no data | |||
6,372,910 | US$21.3m | 96.8% | 0.01% | |||
6,105,679 | US$20.4m | 0% | no data | |||
5,660,719 | US$18.9m | -7.61% | 0.14% | |||
5,353,248 | US$17.9m | 1.55% | no data | |||
5,266,775 | US$17.6m | 3.06% | no data | |||
4,890,313 | US$16.3m | -19.6% | no data | |||
4,361,078 | US$14.6m | 0% | no data | |||
3,736,707 | US$12.5m | -4.71% | 6.63% | |||
2,198,240 | US$7.3m | 65.2% | 0.01% | |||
2,074,350 | US$6.9m | 0% | 0.36% | |||
1,792,210 | US$6.0m | 0% | 6.99% | |||
1,359,979 | US$4.5m | 4.89% | no data | |||
1,146,949 | US$3.8m | 3.9% | no data | |||
1,070,000 | US$3.6m | 138% | 0.27% | |||
1,028,466 | US$3.4m | 0% | 0.03% | |||
965,001 | US$3.2m | 0% | no data | |||
896,960 | US$3.0m | 0% | 0.05% | |||
750,000 | US$2.5m | 0% | 0.01% | |||
733,001 | US$2.4m | 12.3% | 0.14% | |||
700,000 | US$2.3m | 0% | 0.08% | |||
694,000 | US$2.3m | 0% | 0.12% |